Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
Michael D. Hill et al.
LANCET (2020)
Management of acute ischemic stroke
Michael S. Phipps et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Angiotensin Converting Enzyme 2 A Double-Edged Sword
Kaiming Wang et al.
CIRCULATION (2020)
Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization
Ladonya Jackson et al.
TRANSLATIONAL STROKE RESEARCH (2020)
Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke
Tauheed Ishrat et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke
Douglas M. Bennion et al.
EXPERIMENTAL PHYSIOLOGY (2018)
Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice
Katja Schwengel et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Valery L. Feigin et al.
LANCET NEUROLOGY (2016)
Hematological disorders: a commonly unrecognized cause of acute stroke
Adria Arboix et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress
Dominik Wincewicz et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2015)
Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage
Li-Juan Min et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
Cerebroprotective action of angiotensin peptides in stroke
Robert W. Regenhardt et al.
CLINICAL SCIENCE (2014)
Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice
Jun Iwanami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats
Robert W. Regenhardt et al.
EXPERIMENTAL PHYSIOLOGY (2014)
The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke
Jason P. Joseph et al.
NEUROPHARMACOLOGY (2014)
Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats
Claudia A. McCarthy et al.
PLOS ONE (2014)
Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells
Feng Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke
Robert W. Regenhardt et al.
NEUROPHARMACOLOGY (2013)
AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Ahmed Alhusban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
The Role of Angiotensin II Receptors in Stroke Protection
Steven G. Chrysant
CURRENT HYPERTENSION REPORTS (2012)
Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats
Claudia A. McCarthy et al.
HYPERTENSION (2012)
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
Antoni Davalos et al.
LANCET (2012)
Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
Masatsugu Horiuchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Impact of Hypertension on Stroke
Jordan Dubow et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke
Adam P. Mecca et al.
EXPERIMENTAL PHYSIOLOGY (2011)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Else Charlotte Sandset et al.
LANCET (2011)
Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
Katia Daniela da Silveira et al.
JOURNAL OF IMMUNOLOGY (2010)
The complexity of neurobiological processes in acute ischemic stroke
R. Brouns et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Cognitive Deficit in Amyloid-β-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
Kana Tsukuda et al.
HYPERTENSION (2009)
Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke
Claudia A. McCarthy et al.
STROKE (2009)
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
Guo-Cai Lu et al.
STROKE (2009)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Increased Aortic Pulse Wave Velocity Is Associated With Silent Cerebral Small-Vessel Disease in Hypertensive Patients
Leon H. G. Henskens et al.
HYPERTENSION (2008)
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats
Maxim Krikov et al.
JOURNAL OF HYPERTENSION (2008)
Small artery remodelling in hypertension: causes, consequences and therapeutic implications
Michael J. Mulvany
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING (2008)
Renin-angiotensin system and stroke
Simona Marcheselli et al.
NEUROLOGICAL SCIENCES (2008)
Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review
Bart Stragier et al.
HEART FAILURE REVIEWS (2008)
Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups
Harold P. Adams et al.
STROKE (2007)
Inhibition of the renin-angiotensin system and the prevention of stroke
Joachim Schrader et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2007)
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats
J Zhou et al.
STROKE (2006)
Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk
S Kumar et al.
NEUROLOGY (2006)
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention
P Verdecchia et al.
HYPERTENSION (2005)
The AT2 receptor - A matter of love and hate
UM Steckelings et al.
PEPTIDES (2005)
Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity
M Selim et al.
BMC NEUROLOGY (2005)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury
J Li et al.
FASEB JOURNAL (2005)
The renin-angiotensin systems: Evolving pharmacological perspectives for cerebroprotection
L Magy et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat
M Lou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats
T Engelhorn et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation
M Iwai et al.
CIRCULATION (2004)
Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke
A Arboix et al.
CEREBROVASCULAR DISEASES (2004)
Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo:: role of the AT2 receptor and the transcription factor NF-κB
K Reinecke et al.
FASEB JOURNAL (2003)
Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats
T Kagiyama et al.
REGULATORY PEPTIDES (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Ischemic injury in experimental stroke depends on angiotensin II
T Walther et al.
FASEB JOURNAL (2002)
Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy - An invited review
PB Gorelick
STROKE (2002)
Challenges for the prevention of primary and secondary stroke - The importance of lowering blood pressure and total cardiovascular risk
J Chalmers et al.
BLOOD PRESSURE (2001)
Independent association of high blood pressure and aortic atherosclerosis - A population-based study
Y Agmon et al.
CIRCULATION (2000)
Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats
Y Nishimura et al.
STROKE (2000)
Share Paper
